Hepatitis C vaccine (Aduro BioTech)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHepatitis C vaccine (Aduro BioTech)

Drug Alias NameANZ-521

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis C, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCerus Corp

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHepatitis C, Chronic

ATC CodeN/A